Impact of High Deductible Insurance on Adjuvant Hormonal Therapy Use in Breast Cancer

OBJECTIVE: High-deductible health plans (HDHP) have become the predominant commercial health insurance arrangement in the United States. HDHPs require substantial out-of-pocket (OOP) costs for most services but often exempt medications from high cost sharing. We examined effects of HDHPs on OOP cost...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Lu, Christine Y., Zhang, Fang, Wagner, Anita K., Nekhlyudov, Larissa, Earle, Craig C., Callahan, Matthew, LeCates, Robert, Xu, Xin, Ross-Degnan, Dennis, Wharam, J. Frank
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231999/
https://ncbi.nlm.nih.gov/pubmed/29754304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4821-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky